Viewpoint

DOI: 10.4244/EIJ-E-25-00017

Restoring Europe's global position in medical device innovation

Martine Gilard, MD, PhD, FESC; Bernard Prendergast, MD; William Wijns, MD, PhD; Andreas Baumbach, MD; Francesco Maisano, MD, Marc Doncieux; on behalf of the PCR Board

Research in Europe has historically driven cardiovascular (CV) device innovation, a cornerstone of advancements in our speciality. Patients, who are central to invasive CV procedures and device implantation, benefit from life-saving, minimally invasive treatments that often lead to quicker recovery and improved quality of life. Percutaneous coronary intervention, transcatheter aortic valve implantation, percutaneous mitral valve repair, and cardiovascular implantable electronic devices exemplify innovations that have enabled millions of patients worldwide to enjoy better outcomes.

At a time when American support for scientific research, particularly medical research, has rapidly diminished, accompanied by sustained attacks on staff and the funding of US Department of Health and Human Services (HHS) agencies, such as the National Institutes of Health (NIH) or the U.S. Food and Drug Administration (FDA), research and innovation in Europe have taken on a new level of importance – and urgency.

To ensure continued progress, Europe must foster an environment that is conducive to medical technology development and validation. This approach not only sustains innovation but also maintains the highest safety standards.

The European Union’s (EU) Medical Device Regulation (MDR), adopted in April 2017,...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 21 Number 10
May 16, 2025
Volume 21 Number 10
View full issue


Key metrics

Trending articles
225

State-of-the-Art Review

10.4244/EIJ-D-21-00426 Dec 3, 2021
Myocardial infarction with non-obstructive coronary artery disease
Lindahl B et al
free
172.05

Focus article

10.4244/EIJY19M08_01 Jan 17, 2020
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update
Glikson M et al
free
80.05

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
47

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved